Rigel Pharmaceuticals
RIGL
#6624
Rank
S$1.04 B
Marketcap
S$55.30
Share price
-1.85%
Change (1 day)
-0.17%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2026 (TTM): S$22.71

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$22.76. In 2025 the company made an earnings per share (EPS) of S$26.08 an increase over its 2024 EPS that were of S$1.28.

EPS history for Rigel Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$22.71-12.92%
2025S$26.081944.44%
2024S$1.28
2022S-$4.38240%
2021S-$1.29-37.5%
2020S-$2.06-60%
2019S-$5.15-11.11%
2018S-$5.80-26.23%
2017S-$7.86-17.57%
2016S-$9.5325.42%
2015S-$7.60-42.72%
2014S-$13.27
2012S-$17.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
S$22.39-1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$9.17-59.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
S-$0.49-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
S-$2.43-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA